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Aim: The aim of this studywas to present the process of diagnosis and treatment of a patient
with diagnosed intramuscular myxoma in the left lower limb.
Background:Myxomas are benign neoplasmswhich can be foundwithin largemuscle groups.
Histologically, these neoplasms are composed of a few elongated or star-shaped cells lying
in abundantmucoid stroma. These tumours are characterized by expanding growthwithout
forming distant metastases.
Case description: A man, 58, came to the Surgical Oncology Outpatient Clinic due to pain
ailments and a growing tumour located in the rear group of the left shank muscles. The
patient had been observing the lesion for several years, but related the occurrence of pain
to the change in the nature of his job – from sedentary to standing. The patient underwent
diagnostic imaging, a magnetic resonance imaging test, in which a tumour was described.
A surgery was carried out where the tumour was resected together with the lateral head
of the gastrocnemius muscle. No signiﬁcant walking disorders, neurological deﬁcits, either
sensory or motor were observed. The follow-up imaging examinations, which were carried
out a year after the surgery, did not reveal a relapse. The patient remains under the care of
the Surgical Oncology Outpatient Clinic.Conclusion: Myxomas are a group of benign neoplasms whose ﬁrst symptom is the appear-
ance of a palpable tumour whose stretching growth causes painful ailments. Aftermagnetic
resonance imaging and a diagnosis, it is necessary to plan the surgery. Radical resection of
the lesion is a method of choice which guarantees long-lasting recovery.
© 2011 Greater Poland Cancer Centre, Poland. Published by Elsevier Urban & Partner Sp.. Background
yxomas belong to the group of benign neoplasms which can
e foundwithinmuscles. Similarly to the entire group of pseu-
osarcomatic lesions, theseneoplasmsmay imitate soft tissue
arcoma. Their rapid growth, cellular atypia and increased
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mitotic activity may cause a wrong diagnosis. However, they
are benign neoplasms. Myxomas were ﬁrst described by Stout
in 1948.1 They are characterized by slow growth. The most
frequent location of those neoplasms is the cardiac muscle,
where they account for 50% of all benign lesions.2 Apart from
the cardiac muscle, more than a half of all myxomas can
be found within thigh muscles. Some other much less fre-
. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.
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Fig. 1 – Horizontal cross-section of the tumour in MRI.72 reports of practical oncology a
quent locations include: the buttocks, shoulder girdle, shank,
arm and trunk. In very rare cases myxomas may also be
located within the neck (about a dozen cases described in
the literature).3,4 Some tumours in this group, especially the
aggressive angiomyxoma, may be characterized by predis-
position for local relapse. The incidence is one in a million
population per year.5 Most frequently, they occur in patients
aged between forty and sixty years, more often in women.
The average size of diagnosed lesions ranges between 1.5 and
17 cm.6 Myxomas are also found in ﬁbrous dysplasias such as
Mazabradua or McCune–Albright syndromes. The basic treat-
ment of this type of neoplasms is radical removal of the whole
lesion. At present neither neoadjuvant nor adjuvant therapy
is applied.
2. Aim
Below, we present a patient diagnosed and treated for a shank
tumour diagnosed as myxoma, which had been observed by
the patient for many years.
3. Case description
A man, 58, came to the Surgical Oncology Outpatient Clinic
due to painful ailments and a growing tumour located in the
rear group of the left shank muscles. The patient had been
observing the lesion for several years, but he related the occur-
rence of pain to the change in the nature of his job – from
sedentary to standing. There were no cases of soft tissue neo-
plasms or other neoplasms in the patient’s family. The patient
did not report any injury around the tumour. The physical
examination within the rear group of the left shank mus-
cles revealed a palpable lesion sized about 10 cm, painless,
hard and movable against the base. The patient underwent
diagnostic imaging – a magnetic resonance imaging test, in
which a tumour was described. It was hypointense in T1 and
hyperintense in T2. Its longitudinal dimension was 12 cm,
the sagittal diameter was 6.8 cm and the frontal diameter
was 10 cm. After an intravenous administration of a contrast
medium a slight homogeneous enhancement of the tumour
became visible. The lesion with expanding growth did not
inﬁltrate the vasculo-nervous bundle; it consisted of three sec-
tions separated from each other by septums. In the upper
pole there was a focus with a cross-section of 2 cm and in the
lower pole, 5.0 cm. In the laboratory investigations, no signif-
icant abnormalities were observed. An open surgical biopsy
was carried out. During the surgery, a tumour was diagnosed
with a hard, white capsule with gelatinous, mucous contents
after cutting. The collected biopsy specimens were sent for
histopathological evaluation. Immunohistochemical exami-
nations CD 34, Vimentin, S100 were made. On their basis,
an intramuscular myxoma was diagnosed. Having obtained
the ﬁnal histopathological diagnosis, a decision to carry out
another surgery was made in order to perform a radical resec-
tion of the lesion. A partitioning surgerywas carried outwhere
the tumour was resected together with the lateral head of
the gastrocnemius muscle. No inﬁltration of the posterior
tibial artery, peroneal artery or tibial nerve was diagnosed.The post-operative course did not have any complications.
On the third day following the surgery, the patient was dis-
charged from hospital. When the patient was still at hospital,
he startedmotorial rehabilitation. Finally, no signiﬁcant walk-
ing disorders, neurological deﬁcits, either sensory or motor
were observed. The follow-up imaging examinations, which
were carried out a year after the surgery, did not reveal a
relapse. The patient remains under the care of the Surgical
Oncology Outpatient Clinic (see Figs. 1–4).Fig. 2 – Vertical cross-section of the tumour in MRI.
reports of practical oncology and rad
Fig. 3 – Intraoperative view of the tumour.
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. Discussion
yxomas occurs within various groups of skeletal muscles,
bout 51% within the thigh, 9% in the arm muscles, 7% in the
alf muscles and 7% in the buttock muscles.6 Clinically, these
eoplasms most frequently appear in the form of a painless,
alpable, well-limited lesion. However, in consequence of a
onstant, slow growth the surrounding tissues are stretched
nd pressed on, which results in pain. The occurrence of pain
raws patients’ attention to the lesion and encourages further
iagnostics. In the available literature, pain is described as theiotherapy 1 6 ( 2 0 1 1 ) 71–74 73
ﬁrst symptom of the neoplasm, which is observed in 6–34%
of patients.7 In the described case, the patient began to suffer
from pain when the nature of his job changed from sedentary
to standing. It was also then that he noticed the growth of the
lesion.
Appropriate imaging examinations are a signiﬁcant stage
of myxoma diagnostics. A plain X-ray may be normal or
rarely makes the lesion within soft tissues visible as shading
with calciﬁcations inside.8–10 An ultrasonographic exami-
nation usually visualises hypoechogenic lesions with ﬂuid
compartments located within muscles. The ultrasound image
is not speciﬁc enough and it does not enable diagnosis. The
next stage of diagnosticsmay be computer tomography,which
usually shows a well limited mass with absorption density
contained between the muscle and water. The most precise
examination, which enables diagnosis, is magnetic resonance
imaging.11,12 The radiological diagnostic criteria for soft tis-
sue myxomas were speciﬁed by Peterson13 and then modiﬁed
by Bancfort14 and Murphey.6 A typical image of intramuscular
myxoma in magnetic resonance imaging is a lesion within a
muscle, which has ﬂuid signal intensities, fatty tissue capsule
and T2 hyperintense signal from the surroundingmuscle. The
magnetic resonance image in the presented case was fairly
characteristic. The lesion within the muscle was described
with typical enhancements and inhomogeneous character
(ﬂuid compartments). Carrying outmagnetic resonance imag-
ing is a necessary stage of preoperative diagnostics in the case
of suspected myxoma located inside muscles.15 It also makes
it possible to plan the range of a surgery.
In order to deﬁne the character of a tumour located within
muscles, it is necessary to make a histopathological exami-
nation. The ﬁrst stage may be ﬁne needle aspiration biopsy.
In the cytological smear spindle cells with long cytoplasmic
microfootlets and histiocytes inmucoid stroma can be seen.16
Unfortunately, a ﬁne needle biopsy very often fails to bring
diagnosis or brings one that is uncertain. It is then recom-
mended to carry out a core needle biopsy or an open surgical
biopsy.
Following imaging diagnostics and histopathological diag-
nosis, it is necessary to deliver appropriate therapy. In view
of the fact that myxomas are benign neoplasms, which are
not capable of forming distantmetastases, and the percentage
of local relapses of cellular myxoma is less than 10%, radical
resection of the lesion is recommended.17–19 So far, the avail-
able literature has described no case of distant metastases in
a patient with a myxoma. However, there have been descrip-
tions of relapses after non-radical resection. Neoplasms from
the myxoma group are capable of penetrating the surround-
ingmuscle. Therefore, in the case of an uncertainmacroscopic
margin, resection of the tumour with the surrounding muscle
is recommended. No beneﬁts resulting from either preop-
erative or postoperative radiotherapy in the treatment of
intramuscular myxomas have been proved.20 Another fun-
damental method of treating myxomas located within the
cardiac muscle is a surgical resection of the whole lesion
with a healthy tissue margin. Such a procedure extends the
symptom-free period and guarantees a lowpercentage of local
relapses.21 Thus, regardless of the location, surgical resec-
tion is the most effective method of treating myxomas. In
the presented case, the diagnosis was followed by a partition-
nd ra
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ing surgery with a radical resection of the lesion, which was
conﬁrmed by a histopathological examination. A year after
the surgery no relapse of the growth process was observed
in imaging examinations.
5. Conclusion
Myxomas are a group of benign neoplasms, whose ﬁrst symp-
tom is the appearance of a palpable tumour, whose stretching
growth causes pain. After magnetic resonance imaging and a
diagnosis, it is necessary to plan the surgery. Radical resec-
tion of the lesion is a method of choice, which guarantees
long-lasting recovery.
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